FTV Earnings Date: Feb 3, 2027 (Estimated) — Fortive Corporation
NYSE · Technology · Scientific & Technical Instruments
Updated
When is FTV's next earnings date?
Fortive Corporation (FTV) is expected to report Q4 2026 earnings on Wednesday, February 3, 2027 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.88 on revenue of $1.14B.
How did FTV do in its last earnings report?
In its most recent report on Oct 28, 2026 (Q3 2026), Fortive Corporation posted EPS of $0.77 versus the $0.70 estimate, a beat of 9.4%. Revenue was $1.11B against a $1.07B estimate. The stock's 1-day post-earnings move was +4.0%.
How much does FTV stock move after earnings?
FTV beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.3% (up or down) in the day after earnings.
About Fortive Corporation
Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.
🤖 AI Earnings Analysis
Fortive’s scientific-instrumentation results were solid: Q3 EPS of $0.77 beat estimates by $0.07, while revenue rose 10% year over year to $1.1B. Accruent’s Lucernex ATLAS launch adds a modest software catalyst; EPS guidance remains $2.95–$3.05.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | Q3 2026 | 0.70 | 0.77 | +9.38% | $1.11B | ✅ Beat | +4.04% | — | — |
| 2026-07-29 | Q2 2026 | 0.70 | 0.74 | +5.71% | $1.10B | ✅ Beat | -7.09% | -5.58% | -5.98% |
| 2026-04-30 | Q1 2026 | 0.64 | 0.70 | +9.38% | $1.07B | ✅ Beat | -3.17% | -2.17% | -5.55% |
| 2026-02-04 | Q4 2025 | 0.84 | 0.90 | +7.14% | $1.12B | ✅ Beat | +10.63% | +13.94% | +6.78% |
| 2025-10-29 | Q3 2025 | 0.57 | 0.68 | +19.30% | $1.03B | ✅ Beat | +2.41% | +2.41% | +8.30% |
| 2025-07-30 | Q2 2025 | 0.60 | 0.90 | +50.00% | $1.52B | ✅ Beat | -2.49% | -4.94% | -4.60% |
| 2025-02-07 | Q4 2024 | 1.12 | 1.17 | +4.46% | $1.62B | ✅ Beat | -0.92% | +2.30% | -6.05% |
| 2024-10-30 | Q3 2024 | 0.93 | 0.97 | +4.30% | $1.53B | ✅ Beat | -3.35% | -4.30% | +6.44% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $1.11B total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Intelligent Operating Solutions | 69.3% | $767.1M | +9.4% | $671.4M | $675.7M | $701.2M | $808.0M |
| Advanced Healthcare Solutions | 30.7% | $340.4M | +3.7% | $302.2M | $319.5M | $328.3M | $352.8M |
By region
Q2 FY25 · $1.52B total
| Segment | Share | Revenue | YoY | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 54.3% | $825.2M | -1.8% | $855.4M | $789.9M | $840.3M | $841.9M |
| Countries Excluding United States and China | 35.2% | $533.9M | -2.4% | $555.8M | $558.3M | $547.0M | $538.9M |
| CHINA | 10.5% | $159.7M | -3.3% | $172.5M | $176.3M | $165.1M | $153.8M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.